Aurobindo Pharma Sees 11.14% Surge in Open Interest to 67,032 Contracts
Aurobindo Pharma Ltd. has seen a significant rise in open interest, reaching 67,032 contracts, alongside a trading volume of 27,938 contracts. Despite a slight decline in stock price, investor participation has surged, with delivery volume increasing notably. The stock remains liquid, reflecting changing trading dynamics.
Aurobindo Pharma Ltd. has experienced a notable increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 67,032 contracts, up from the previous figure of 60,314, marking a change of 6,718 contracts or an 11.14% increase. The trading volume for the day reached 27,938 contracts, contributing to a futures value of approximately Rs 98,496.47 lakhs.In terms of price performance, Aurobindo Pharma's stock has shown a slight decline of 1.03% today, which contrasts with the sector's average decline of 0.65% and the Sensex's drop of 0.50%. The stock's weighted average price indicates that more volume was traded closer to its low price for the day. Additionally, the stock is currently trading above its 5-day, 20-day, and 50-day moving averages, but below its 100-day and 200-day moving averages.
Investor participation has also risen, with a delivery volume of 10.26 lakh shares on October 29, reflecting a significant increase of 109.48% compared to the 5-day average. Aurobindo Pharma, with a market capitalization of Rs 64,175 crore, remains a liquid stock, suitable for trades up to Rs 2.58 crore based on 2% of its 5-day average traded value. Overall, the increase in open interest highlights a shift in trading dynamics for Aurobindo Pharma amidst a mixed performance in the broader market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
